Search bioRxiv⌕ Search

bioRxiv · 10.1101/2024.02.27.582361

Decoding Motor Excitability in TMS using EEG-Features:An Exploratory Machine Learning Approach

Abstract

BackgroundWith the burgeoning interest in personalized treatments for brain network disorders, closed-loop transcranial magnetic stimulation (TMS) represents a promising frontier. Relying on the real-time adjustment of stimulation parameters based on brain signal decoding, the success of this approach depends on the identification of precise biomarkers for timing the stimulation optimally. ObjectiveWe aimed to develop and validate a supervised machine learning framework for the individualized prediction of motor excitability states, leveraging a broad spectrum of sensor and source space EEG features. MethodsOur approach integrates multi-scale EEG feature extraction and selection within a nested cross-validation scheme, tested on a cohort of 20 healthy participants. We assessed the frameworks performance across different classifiers, feature sets, and experimental protocols to ensure robustness and generalizability. ResultsPersonalized classifiers demonstrated a statistically significant mean predictive accuracy of 72 {+/-} 11%. Consistent performance across various testing conditions highlighted the sufficiency of sensor-derived features for accurate excitability state predictions. Subtype analysis revealed distinct clusters linked to specific brain regions and oscillatory features as well as the need for a more extensive feature set for effective biomarker identification than conventionally considered. ConclusionsOur machine learning framework effectively identifies predictive biomarkers for motor excitability, holding potential to enhance the efficacy of personalized closed-loop TMS interventions. While the clinical applicability of our findings remains to be validated, the consistent performance across diverse testing conditions and the efficacy of sensor-only features suggest promising avenues for clinical research and wider applications in brain signal classification.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Haxel, L., Belardinelli, P., Ermolova, M., Humaidan, D., Macke, J. H., Ziemann, U.. 2024-02-28. Decoding Motor Excitability in TMS using EEG-Features:An Exploratory Machine Learning Approach. https://doi.org/10.1101/2024.02.27.582361

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗